Investigator Sponsored Research

Rigel is committed to advancing the knowledge of fostamatinib and therapeutic areas of interest. Therefore, Rigel considers requests for product and/or monetary support for independent, investigator sponsored research for such scientific and medical innovation.

Please contact for further information and instructions to apply with our Concept Submission Form.

Proposed studies will be assessed based on scientific merit, validity and rigor of the study, risk/benefit assessment to ensure the safety of human subjects, adherence to ethical guidelines concerning human subjects, consistency with Rigel’s values, and other considerations.